Altyar, A.E.; Afzal, M.; Ghaboura, N.; Alharbi, K.S.; Alenezi, S.K.; Sayyed, N.; Kazmi, I.
Barbaloin Protects Pentylenetetrazol-Induced Cognitive Deficits in Rodents via Modulation of Neurotransmitters and Inhibition of Oxidative-Free-Radicals-Led Inflammation. Pharmaceuticals 2024, 17, 699.
https://doi.org/10.3390/ph17060699
AMA Style
Altyar AE, Afzal M, Ghaboura N, Alharbi KS, Alenezi SK, Sayyed N, Kazmi I.
Barbaloin Protects Pentylenetetrazol-Induced Cognitive Deficits in Rodents via Modulation of Neurotransmitters and Inhibition of Oxidative-Free-Radicals-Led Inflammation. Pharmaceuticals. 2024; 17(6):699.
https://doi.org/10.3390/ph17060699
Chicago/Turabian Style
Altyar, Ahmad Essam, Muhammad Afzal, Nehmat Ghaboura, Khalid Saad Alharbi, Sattam Khulaif Alenezi, Nadeem Sayyed, and Imran Kazmi.
2024. "Barbaloin Protects Pentylenetetrazol-Induced Cognitive Deficits in Rodents via Modulation of Neurotransmitters and Inhibition of Oxidative-Free-Radicals-Led Inflammation" Pharmaceuticals 17, no. 6: 699.
https://doi.org/10.3390/ph17060699
APA Style
Altyar, A. E., Afzal, M., Ghaboura, N., Alharbi, K. S., Alenezi, S. K., Sayyed, N., & Kazmi, I.
(2024). Barbaloin Protects Pentylenetetrazol-Induced Cognitive Deficits in Rodents via Modulation of Neurotransmitters and Inhibition of Oxidative-Free-Radicals-Led Inflammation. Pharmaceuticals, 17(6), 699.
https://doi.org/10.3390/ph17060699
